RESUMEN
Many patients with established end-stage renal disease on maintenance dialysis as a result of lupus nephritis are young females in their reproductive years. We report two such patients dialyzed with on-line hemodiafiltration who developed reactivation of lupus disease activity only when they conceived after initial systemic lupus erythematosus burnout. We believe that the flare was triggered by both efficient dialysis and hormonal changes during pregnancy. The flares were treated with oral corticosteroids with an excellent response. Both patients had live births but delivered preterm.
Asunto(s)
Fallo Renal Crónico/complicaciones , Nefritis Lúpica/etiología , Adulto , Femenino , Hemodiafiltración , Humanos , Fallo Renal Crónico/terapia , EmbarazoRESUMEN
BACKGROUND: Hepatitis C virus (HCV) is a major cause of hepatitis in hemodialysis (HD) patients. Routes other than blood transfusion play a role in the spread of HCV in HD patients. Molecular studies of HCV implicate nosocomial transmission of the virus in HD units. We conducted a clinicovirological study in our HD unit to investigate if the hands of dialysis personnel could represent a mode of transmission of HCV among HD patients. METHODS: One liter of sterile water was used for each handwashing of dialysis personnel. The washing was collected in a sterile container and tested for HCV-RNA by polymerase chain reaction (PCR) within 3 h of collection. Eighty handwashings from nurses dialyzing HCV-positive patients (groupe A) and 100 handwashing from nurses dialyzing HCV-negative patients (group B) were tested for HCV-RNA. As a control, 60 handwashings were collected from the dialysis personnel before entering the dialysis unit (group C) and tested for HCV-RNA. RESULTS: HCV-RNA was positive in 19 (23.75%) of samples of group A, in 8 (8%) of samples of group B (p < 0.003) and in 2 (3.3%) of samples of group C (p < 0. 35). These two positive samples of group C were from nurses who had dialyzed HCV-negative patients. CONCLUSION: These results indicate the presence of HCV-RNA on the hands of some dialysis personnel in our HD unit, in spite fo adherence to the standard precautions. The hands of dialysis personnel are therefore a potential mode for facilitating transmission of HCV between HD patients.
Asunto(s)
Mano/virología , Hepacivirus/aislamiento & purificación , Hepatitis C/transmisión , Transmisión de Enfermedad Infecciosa de Paciente a Profesional , Enfermeras Practicantes , Diálisis Renal , Infección Hospitalaria/prevención & control , Infección Hospitalaria/transmisión , Infección Hospitalaria/virología , Cartilla de ADN/química , Desinfección de las Manos , Unidades de Hemodiálisis en Hospital , Hepacivirus/genética , Hepatitis C/virología , Anticuerpos contra la Hepatitis C/análisis , Humanos , ARN Viral/análisis , Reacción en Cadena de la Polimerasa de Transcriptasa InversaRESUMEN
We describe a female patient who received double pediatric (en bloc) kidney transplants. She presented initially with fever of unknown origin 3 months after transplantation; 5 months after surgery, she presented with obstruction of one ureter followed by obstruction of the other. After 9 months she developed posttransplant lymphoproliferative disorder in both kidneys. To our knowledge, this is the first case report of this disorder occurring in en bloc kidneys and presenting with bilateral ureteric obstruction.
Asunto(s)
Neoplasias Renales/etiología , Trasplante de Riñón/efectos adversos , Linfoma de Células B/etiología , Obstrucción Ureteral/etiología , Adulto , Biopsia , Diagnóstico Diferencial , Femenino , Rechazo de Injerto/tratamiento farmacológico , Herpesvirus Humano 4/genética , Herpesvirus Humano 4/aislamiento & purificación , Humanos , Inmunosupresores/uso terapéutico , Hibridación in Situ , Neoplasias Renales/diagnóstico , Neoplasias Renales/cirugía , Neoplasias Renales/virología , Trasplante de Riñón/patología , Linfoma de Células B/diagnóstico , Linfoma de Células B/cirugía , Linfoma de Células B/virología , Nefrectomía , ARN Viral/análisis , Reoperación , Tomografía Computarizada por Rayos X , Obstrucción Ureteral/diagnóstico , Obstrucción Ureteral/cirugíaAsunto(s)
Supervivencia de Injerto , Trasplante de Riñón/estadística & datos numéricos , Adolescente , Adulto , Anciano , Niño , Preescolar , Infecciones por Citomegalovirus/epidemiología , Femenino , Estudios de Seguimiento , Rechazo de Injerto/epidemiología , Hospitales Especializados , Humanos , Trasplante de Riñón/mortalidad , Trasplante de Riñón/fisiología , Masculino , Persona de Mediana Edad , Neoplasias/epidemiología , Complicaciones Posoperatorias/epidemiología , Estudios Retrospectivos , Arabia Saudita/epidemiología , Tasa de Supervivencia , Factores de Tiempo , Donantes de TejidosAsunto(s)
Supervivencia de Injerto/fisiología , Trasplante de Riñón/fisiología , Donantes de Tejidos/clasificación , Adolescente , Adulto , Factores de Edad , Cadáver , Niño , Preescolar , Femenino , Humanos , Lactante , Trasplante de Riñón/inmunología , Trasplante de Riñón/mortalidad , Masculino , Estudios Retrospectivos , Análisis de SupervivenciaAsunto(s)
Ciclosporina/uso terapéutico , Trasplante de Riñón/inmunología , Administración Oral , Adulto , Suero Antilinfocítico/uso terapéutico , Transfusión Sanguínea , Cadáver , Ciclosporina/administración & dosificación , Formas de Dosificación , Quimioterapia Combinada , Emulsiones , Femenino , Estudios de Seguimiento , Supervivencia de Injerto , Humanos , Trasplante de Riñón/mortalidad , Trasplante de Riñón/fisiología , Donadores Vivos , Masculino , Muromonab-CD3/uso terapéutico , Estudios Retrospectivos , Análisis de Supervivencia , Factores de Tiempo , Donantes de Tejidos , Resultado del TratamientoAsunto(s)
Supervivencia de Injerto , Soluciones Hipertónicas , Trasplante de Riñón/fisiología , Riñón , Soluciones Preservantes de Órganos , Preservación de Órganos/métodos , Adenosina , Adolescente , Adulto , Alopurinol , Niño , Preescolar , Femenino , Estudios de Seguimiento , Glutatión , Humanos , Insulina , Masculino , Persona de Mediana Edad , Rafinosa , Estudios Retrospectivos , Factores de TiempoAsunto(s)
Ceguera/etiología , Diálisis Renal/efectos adversos , Adulto , Femenino , Humanos , Hipotensión/complicacionesRESUMEN
Nocardia is a serious opportunistic infection in renal transplant recipients and nocardial brain abscess in these patients has a high mortality. In addition to antimicrobial therapy, treatment usually involves craniotomy and excision of the abscess. We describe a renal transplant recipient maintained on cyclosporine and prednisone developing Nocardia Asteroides brain abscess. After stereotactic aspiration of the abscess, successful treatment was achieved by triple therapy with trimethoprim sulfamethoxazole (TMP/SMX), ceftriaxone and amikacin. The allograft function remained stable. Long-term prophylaxis with TMP/SMX is necessary to prevent the relapse of nocardia.
Asunto(s)
Absceso Encefálico/tratamiento farmacológico , Absceso Encefálico/microbiología , Quimioterapia Combinada/uso terapéutico , Terapia de Inmunosupresión/efectos adversos , Trasplante de Riñón , Nocardiosis/tratamiento farmacológico , Nocardia asteroides , Infecciones Oportunistas/tratamiento farmacológico , Amicacina/uso terapéutico , Ceftriaxona/uso terapéutico , Humanos , Inmunosupresores/uso terapéutico , Masculino , Persona de Mediana Edad , Nocardiosis/etiología , Infecciones Oportunistas/etiología , Resultado del Tratamiento , Combinación Trimetoprim y Sulfametoxazol/uso terapéuticoRESUMEN
Kaposi's sarcoma (KS) and non-Hodgkin's lymphoma are frequent complications of renal transplantation that usually occur as separate entities. We describe a young woman who simultaneously developed Kaposi's sarcoma and lymphoma after kidney transplantation. Immunosuppression consisted of cyclosporine and prednisone with normal serum creatinine. Fifteen months after transplantation, she developed Kaposi's sarcoma skin lesions, generalized lymphadenopathy, and ascites. A lymph node biopsy showed both Kaposi's sarcoma and lymphoma in the same tissue specimen with Epstein-Barr viral genomes within the tumor cells. Graft function remained normal. Cyclosporine was discontinued, and treatment with acyclovir was started, but the patient's condition rapidly deteriorated, and she died. This is the first case in which both Kaposi's sarcoma and lymphoma were present in the same biopsy specimen. After renal transplantation, more than one tumor can develop either simultaneously or in succession.
Asunto(s)
Trasplante de Riñón , Linfoma no Hodgkin/diagnóstico , Neoplasias Primarias Múltiples/diagnóstico , Complicaciones Posoperatorias/diagnóstico , Sarcoma de Kaposi/diagnóstico , Neoplasias Cutáneas/diagnóstico , Adulto , Biopsia , Resultado Fatal , Femenino , Humanos , Ganglios Linfáticos/patología , Piel/patología , Factores de TiempoRESUMEN
In this report we present two cases of acute renal failure in paroxysmal nocturnal hemoglobinuria (PNH) patients, who both eventually recovered their renal function. We also highlight some of the possible pathophysiological changes, which may contribute to renal failure in patients with PNH.
RESUMEN
PURPOSE: To compare the yield and complications of ultrasound-guided gun-biopsy and manual Tru-Cut techniques in percutaneous renal biopsy. MATERIAL AND METHODS: A total of 448 biopsies were reviewed. They comprised 124 manual and 131 gun-biopsies in native kidneys, and 111 manual and 82 gun-biopsies in transplant kidneys. The gun-biopsies were performed under real-time ultrasound (US) guidance. The manual technique used US mainly for marking the position of the kidney. RESULTS: There was a significantly higher diagnostic yield and fewer complications in the gun-biopsy group. A total of 8 major complications were found, all in the manual group. CONCLUSION: Provided that the operator is experienced in US scanning, a switch from the manual technique to real-time US-guided gun-biopsy will result in the improvement of diagnostic accuracy together with a reduced risk of complications.
Asunto(s)
Biopsia con Aguja/métodos , Trasplante de Riñón/patología , Riñón/patología , Ultrasonografía Intervencional , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Fístula Arteriovenosa/etiología , Biopsia con Aguja/efectos adversos , Transfusión Sanguínea , Niño , Preescolar , Femenino , Hematoma/etiología , Hematuria/etiología , Humanos , Lactante , Riñón/diagnóstico por imagen , Riñón/cirugía , Glomérulos Renales/patología , Trasplante de Riñón/diagnóstico por imagen , Masculino , Persona de Mediana Edad , Nefrostomía Percutánea , Factores de Riesgo , Irrigación Terapéutica , Ultrasonografía Intervencional/efectos adversos , Vejiga Urinaria/lesionesRESUMEN
The performance of two new hepatitis C virus antibody (anti-HCV) assays (a third-generation immunoglobulin (Ig)G recombinant immunoblot assay (RIBA 3.0) and hepatitis C virus core IgM (HCV IgM) in the prediction of hepatitis C viremia in hemodialysis patients was compared with that of a second-generation IgG recombinant immunoblot assay (RIBA 2.0). Forty-three patients on maintenance hemodialysis were studied. Aliquots of sera were tested prospectively for anti-HCV by RIBA 2.0, RIBA 3.0, and HCV IgM and for HCV RNA by polymerase chain reaction. Thirty-eight patients were HCV RNA positive. Among those, 7 (18%) were HCV IgM positive, 22 (58%) were RIBA 2.0 positive, and 29 (76%) were RIBA 3.0 positive. All but one viremic patients detected by HCV IgM were also detected by RIBA 2.0 and RIBA 3.0. All viremic patients detected by RIBA 2.0 were also detected by RIBA 3.0. RIBA 3.0 was more sensitive than RIBA 2.0 and HCV IgM in the detection of viremic patients (P = 0.0156 and < 0.0001, respectively). The positive predictive value for HCV IgM was 100% as compared with 96 and 97% for RIBA 2.0 and RIBA 3.0, respectively. The negative predictive value for RIBA 3.0 was 36% as compared with 24 and 14% for RIBA 2.0 and HCV IgM, respectively. At 6-months follow-up of the eight viremic patients without a detectable IgM or IgG anti-HCV response, all patients remained RIBA 2.0 nonreactive, one became RIBA 3.0 indeterminate, and one became HCV IgM positive. These data suggest that HCV IgM has poor sensitivity in the detection of hepatitis C viremia and RIBA 3.0 improves the sensitivity of IgG anti-HCV assays in the early detection of hepatitis C viremia in hemodialysis patients.
Asunto(s)
Hepacivirus/aislamiento & purificación , Anticuerpos contra la Hepatitis C/análisis , Hepatitis C/diagnóstico , Inmunoensayo/métodos , ARN Viral/análisis , Diálisis Renal , Viremia/diagnóstico , Adolescente , Adulto , Secuencia de Bases , Femenino , Humanos , Masculino , Persona de Mediana Edad , Datos de Secuencia Molecular , Reacción en Cadena de la PolimerasaRESUMEN
The pharmacokinetics of total and free (ultrafilterable) platinum were investigated in a patient with cervical cancer with ureteric obstruction who, at the time of carboplatin administration, appeared to have a mild renal impairment (i.e., creatinine clearance 1 mL/s), but developed an acute renal failure shortly thereafter, which required hemodialysis. The decline in the concentration of total or free Pt in plasma as function of time correlated well (P < 0.0098) with that of serum creatinine concentration. The elimination half-lives (t1/2) of total and free Pt in this patient were eight- and nine-fold longer than those observed earlier for patients with normal renal function, and the total body clearance was 12.4% and 18.4%, respectively. Although t1/2 of Pt during dialysis was two to three times (total Pt) and eight times (free Pt) shorter than those observed before and after dialysis, three sessions of hemodialysis removed only 5.6% of total Pt and 9.3% of free Pt. Because the pre- and post-dialysis t1/2 values were similar, hemodialysis apparently had no impact on the intrinsic elimination of Pt in this patient.
Asunto(s)
Antineoplásicos/farmacocinética , Carboplatino/farmacocinética , Carcinoma de Células Escamosas/metabolismo , Diálisis Renal , Obstrucción Ureteral/metabolismo , Neoplasias del Cuello Uterino/metabolismo , Lesión Renal Aguda/complicaciones , Lesión Renal Aguda/metabolismo , Lesión Renal Aguda/terapia , Adulto , Carboplatino/administración & dosificación , Carcinoma de Células Escamosas/complicaciones , Femenino , Semivida , Humanos , Tasa de Depuración Metabólica , Factores de Tiempo , Obstrucción Ureteral/etiología , Neoplasias del Cuello Uterino/complicacionesRESUMEN
Renal transplantation offers patients with end-stage renal disease the best opportunity for rehabilitation and long-term survival. However, there is a critical shortage of transplantable kidneys worldwide. This plays well into the hands of transplanters and entrepreneurs involved in commercial renal transplantation, particularly in India. This practice has been condemned by all transplant societies. In our fight against rampant commercialism in renal transplantation, we sought to describe feelings of patients who had received transplants in India, and the difficulties they faced during their stay there. The results show that the two reasons that motivated patients to go to India were lack of living-related donors and the need for prompt transplant. More than half of the patients did not meet their donors. Their experience, however, has been largely positive except for some negative feelings toward the broker and the standard of hospital hygiene. The total cost of the transplant was far less than that in the West but, despite that, some patients felt financially exploited. Communication with them was poor, as most patients did not get adequate pretransplant education and were not informed of possible complications including rejection and graft loss. Furthermore, almost half of the patients were not given medical reports. These results substantiate the impression that CRT in India does not conform to the high standards of renal transplant medicine.
Asunto(s)
Actitud Frente a la Salud , Comercio , Internacionalidad , Trasplante de Riñón/psicología , Obtención de Tejidos y Órganos/métodos , Adolescente , Adulto , Anciano , Costos y Análisis de Costo , Femenino , Financiación Personal , Estudios de Seguimiento , Rechazo de Injerto/etiología , Supervivencia de Injerto , Humanos , India , Relaciones Interpersonales , Fallo Renal Crónico/rehabilitación , Fallo Renal Crónico/cirugía , Trasplante de Riñón/efectos adversos , Trasplante de Riñón/economía , Trasplante de Riñón/normas , Masculino , Registros Médicos , Persona de Mediana Edad , Motivación , Educación del Paciente como Asunto , Relaciones Médico-Paciente , Arabia Saudita , Sociedades Médicas , Donantes de Tejidos , Obtención de Tejidos y Órganos/normasRESUMEN
The authors compared the diagnostic performance of a second-generation recombinant immunoblot assay (RIBA) (RIBA HCV 2.0 SIA) and the recently introduced third-generation RIBA (RIBA HCV 3.0 SIA) with that of hepatitis C virus (HCV) RNA by the polymerase chain reaction (PCR) in 55 patients on chronic hemodialysis. Compared with HCV RNA by PCR, RIBA 3.0 increased the sensitivity of HCV detection to 72% as compared with 56% of RIBA 2.0. Both assays underestimated the prevalence of HCV infection as determined by PCR. However, RIBA HCV 3.0 outperformed RIBA HCV 2.0, detecting all of the RIBA 2.0-positive patients plus an additional eight (8 of 22 RIBA 2.0 negative; confidence interval [CI] = [17.2%, 59.3%]). Forty-three of 51 patients with positive RIBA 3.0 or positive HCV RNA by PCR underwent a liver biopsy. Thirty (70%) had chronic hepatitis (three with cirrhosis), 10 (23%) had nonspecific changes, and three (7%) had normal liver histology. Thirty of 37 patients (81%) with hepatitis C viremia and positive anti-HCV had chronic hepatitis, whereas none of the viremic patients with negative anti-HCV had chronic hepatitis. Among the reactive antigens on RIBA 3.0, c33c was found to be most predictive of chronic hepatitis (P = 0.0002). Detection of HCV RNA continues to be the method of choice in the early phase of HCV infection. In places where a validated HCV RNA assay is not available, RIBA HCV 3.0 (soon to be commercially available) is a better alternative. Early detection of HCV infection and the implementation of an isolation strategy might be important in preventing the spread of HCV infection among hemodialysis patients.(ABSTRACT TRUNCATED AT 250 WORDS)
Asunto(s)
Hepatitis C/diagnóstico , Diálisis Renal , Adolescente , Adulto , Secuencia de Bases , Femenino , Hepatitis C/patología , Humanos , Immunoblotting , Hígado/patología , Masculino , Persona de Mediana Edad , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa , ARN Viral , Viremia/diagnósticoRESUMEN
One hundred and forty kidney transplant recipients were evaluated to study the impact of hepatitis C virus (HCV) infection on patient and graft outcome. There .were 98 males arid 42 females with a mean age of 32.1 +/- 13 years. The duration of follow-up ranged from 6-60 months with a mean period of 27.8 +/- 18.2 months. Seventy-four (53%) patients had received cadaveric kidneys while 66 (47%) received living donor grafts. Anti-HCV reactivity was tested using second generation enzyme-linked immunosorbent assay and positivity was confirmed by recombinant immunoblot assay. HCV infection was diagnosed in 29 cases (20.7%) while HBsAg was found in nine (6.4%) and concomitant anti-HCV and HBsAg positivity was observed in two patients (1.4%). Seventeen of 29 (58.6%) patients with anti-HCV reactivity showed elevated ALT levels as against 17 of 111 (17.3%) anti-HCV non-reactive patients (P< 0.001). There was no association between the sex of the patient, source of the graft, and anti-HCV reactivity. Serum creatinine values were higher in the anti-HCV positive group, but this did not rank to statistical significance. We observed a significantly higher graft loss among the anti-HCV reactive group (27.6% versus 1.8%, P< 0.003). Thirteen anti-HCV reactive patients were subjected to 18 liver biopsies; the commonest lesion observed was chronic active hepatitis, which was progressive in two patients subjected to re-biopsy. We conclude that HCV infection is a serious health problem among kidney transplant recipients and it significantly affects the graft outcome.